Feed Category: Healthcare

A Beverly Hills surgeon is suing Medtronic claiming patent infringement of her hernia repair mesh product. It’s the latest in a series of patent challenges… [Read More]

Oura CEO Tom Hale spoke to CNBC about the smart ring product category and the impact of Samsung’s entrance into the space. Hale said the… [Read More]

Release Date: November 13, 2024 For the complete transcript of the earnings call, please refer to the full earnings call transcript. OptimizeRx Corp (NASDAQ:OPRX) reported… [Read More]

Release Date: November 13, 2024 For the complete transcript of the earnings call, please refer to the full earnings call transcript. OptimizeRx Corp (NASDAQ:OPRX) reported… [Read More]

Revenue: $1.2 million, a 20% increase quarter-on-quarter and a 50% increase year-over-year. Test Volume: 2,787 tests conducted in the third quarter. Gross Margin per Test:… [Read More]

Revenue: $1.2 million, a 20% increase quarter-on-quarter and a 50% increase year-over-year. Test Volume: 2,787 tests conducted in the third quarter. Gross Margin per Test:… [Read More]

OptimizeRx Corp. (OPRX) came out with quarterly earnings of $0.12 per share, beating the Zacks Consensus Estimate of $0.06 per share. This compares to earnings… [Read More]

LEHI, Utah, November 13, 2024–(BUSINESS WIRE)–Owlet, Inc. (“Owlet” or the “Company”) (NYSE:OWLT), the pioneer of smart infant monitoring, today reports financial results for the third… [Read More]

– Q3 revenue of $21.3 million, increasing 30% year-over-year – Q3 gross profit increased 37% year-over-year to $13.4 million with a gross margin of 63% –… [Read More]

Amgen said there is no link between its experimental weight loss drug, MariTide, and changes in bone density. The statement comes a day after that… [Read More]

Amgen said there is no link between its experimental weight loss drug, MariTide, and changes in bone density. The statement comes a day after that… [Read More]

Company to announce improvements in Margins, Operational Efficiency, and a shift to positive Adjusted EBITDA REDWOOD CITY, Calif., Nov. 13, 2024 (GLOBE NEWSWIRE) — Biotricity… [Read More]